What is your strategy for assessment of mutations from a liquid biopsy in metastatic breast cancer that has progressed on multiple therapies?

The use of liquid biopsies in patients with metastatic breast cancer who have progressed on multiple therapies is primarily useful for patients eligible and interested in clinical trials in order to prioritize or qualify patients for targeted therapies. Concordance with results from tissue based tes...